talidomid accord 50 mg trde kapsule
talidomid - kapsula, trda - talidomid 50 mg / 1 kapsula - talidomid
lenalidomid grindeks 10 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 10 mg / 1 kapsula - lenalidomid
lenalidomid grindeks 15 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 15 mg / 1 kapsula - lenalidomid
lenalidomid grindeks 25 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 25 mg / 1 kapsula - lenalidomid
lenalidomid grindeks 5 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 5 mg / 1 kapsula - lenalidomid
thiotepa riemser
esteve pharmaceuticals gmbh - tiotepa - hematopoietic stem cell transplantation; neoplasms - antineoplastična sredstva - thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients. thiotepa riemser is indicated, in combination with other chemotherapy medicinal products:with or without total body irradiation (tbi), as conditioning treatment prior to allogeneic or autologous haematopoietic progenitor cell transplantation (hpct) in haematological diseases in adult and paediatric patients;when high dose chemotherapy with hpct support is appropriate for the treatment of solid tumours in adult and paediatric patients.
abecma
bristol-myers squibb pharma eeig - idecabtagene vicleucel - multiple myeloma; neoplasms; cancer; neoplasms, plasma cell; hemostatic disorders; vascular diseases; cardiovascular diseases; paraproteinemias; blood protein disorders; hematologic diseases; hemic and lymphatic diseases; hemorrhagic disorders; infectious mononucleosis; lymphoproliferative disorders; immunoproliferative disorders; immune system diseases - antineoplastična sredstva - abecma is indicated for the treatment of adult patients with relapsed and refractory multiple myeloma who have received at least three prior therapies, including an immunomodulatory agent, a proteasome inhibitor and an anti cd38 antibody and have demonstrated disease progression on the last therapy.
karmustin tillomed pharma 100 mg prašek in vehikel za koncentrat za infundiranje
karmustin - prašek in vehikel za koncentrat za raztopino za infundiranje - karmustin 100 mg / 1 viala - karmustin
lenabdor 15 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 15 mg / 1 kapsula - lenalidomid
lenabdor 2,5 mg trde kapsule
lenalidomid - kapsula, trda - lenalidomid 2,5 mg / 1 kapsula - lenalidomid